Letter on "(1,3)-β-D-Glucan-based empirical antifungal interruption in suspected invasive candidiasis: a randomized trial".

Details

Ressource 1Download: 33563306_BIB_155FE2BCB2B9.pdf (886.56 [Ko])
State: Public
Version: Final published version
License: CC BY 4.0
Serval ID
serval:BIB_155FE2BCB2B9
Type
Article: article from journal or magazin.
Publication sub-type
Letter (letter): Communication to the publisher.
Collection
Publications
Institution
UNIL/CHUV
Title
Letter on "(1,3)-β-D-Glucan-based empirical antifungal interruption in suspected invasive candidiasis: a randomized trial".
Journal
Critical care
Author(s)
Kritikos A., Lamoth F.
ISSN
1466-609X (Electronic)
ISSN-L
1364-8535
Publication state
Published
Issued date
09/02/2021
Peer-reviewed
Oui
Volume
25
Number
1
Pages
55
Language
english
Notes
Publication types: Letter ; Comment
Publication Status: epublish
Keywords
Antifungal Agents/therapeutic use, Candidiasis, Invasive/diagnosis, Candidiasis, Invasive/drug therapy, Glucans, Humans, beta-Glucans
URN
urn:nbn:ch:serval-BIB_155FE2BCB2B90
OAI-PMH
oai:serval.unil.ch:BIB_155FE2BCB2B9
DOI
10.1186/s13054-020-03450-z
Pubmed
33563306
Web of science
000617714200001
Open Access
Yes
Create date
22/02/2021 11:50
Last modification date
12/01/2022 7:08
Usage data